[go: up one dir, main page]

Prichard et al., 1988 - Google Patents

Effect in man of aspirin, standard indomethacin, and sustained release indomethacin preparations on gastric bleeding.

Prichard et al., 1988

View PDF
Document ID
9961183499612814359
Author
Prichard P
Poniatowska T
Willars J
Ravenscroft A
Hawkey C
Publication year
Publication venue
British journal of clinical pharmacology

External Links

Snippet

1. We have compared acute gastric bleeding caused by a new slow release preparation of indomethacin (indomethacin Continus) with that caused by aspirin and other indomethacin preparations. 2. In a randomized crossover study, blood loss into timed gastric aspirates was …
Continue reading at bpspubs.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
US4880794A (en) Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
Nizankowska et al. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma
Oosterhuis et al. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.
US6376545B1 (en) Dispersible compositions containing L-DOPA ethyl ester
Solomon et al. Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: is advanced age a risk factor?
Ligumsky et al. Rectal Administration of Nonsteroidal Andinflammatory Drugs: Effect on Rat Gastric Ulcerogenicity and Prostaglandin E2 Synthesis
US4960765A (en) Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
O'Laughlin et al. Healing of aspirin-associated peptic ulcer disease despite continued salicylate ingestion
Dressman et al. Absorption of flurbiprofen in the fed and fasted states
Bosse et al. Delayed toxidromes
Stern et al. Protective effect of acetaminophen against aspirin-and ethanol-induced damage to the human gastric mucosa
Smith et al. Preliminary studies of absorption and excretion of benoxaprofen in man.
Prichard et al. Effect in man of aspirin, standard indomethacin, and sustained release indomethacin preparations on gastric bleeding.
La Villa et al. Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure
Moore et al. Age does not influence acute aspirin-induced gastric mucosal damage
Leonards Absence of gastrointestinal bleeding following administration of salicylsalicylic acid
Arvanitakis et al. Effect of aspirin on intestinal absorption of glucose, sodium, and water in man.
Müller et al. An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure
US5034379A (en) Pharmaceutical formulation containing azapropazone
Woods et al. Intragastric accumulation of Evan's blue as a method for assessing aspirin-induced acute gastric mucosal injury in humans
Massarella et al. The influence of food on the pharmacokinetics and ACE inhibition of cilazapril.
Van Gelderen et al. The bioavailability of diclofenac from enteric coated products in healthy volunteers with normal and artificially decreased gastric acidity
Treiber et al. Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal function
Schneider et al. Evaluation of an oral prolonged-release antibiotic formulation
Anderson et al. Urinary excretion of mecillinam by volunteers receiving film-coated tablets of pivmecillinam hydrochloride